Regulatory News has published 1 story about Matisse Pharmaceuticals on 18 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 18 September 2026.
This page is generated from Regulatory News’ editorial coverage of Matisse Pharmaceuticals. It is not an advertisement.
On the record
- Company
- Matisse Pharmaceuticals B.V. (privately held)
- Headquarters
- Brightlands Chemelot Campus, Geleen, the Netherlands
- Founded
- 2014
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
